Maternus-Kliniken AG (STU:MAK) Margin of Safety % (DCF FCF Based): N/A (As of Jun. 26, 2026)


STU:MAK Maternus-Kliniken AG STU:MAK
38 GF Score
Price €0.95
GF Value €1.77
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Maternus-Kliniken AG Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Maternus-Kliniken AG's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

STU:MAK vs HCA, THC, DVA: Margin of Safety % (DCF FCF Based) Comparison

For the Medical Care Facilities subindustry, Maternus-Kliniken AG's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Maternus-Kliniken AG Margin of Safety % (DCF FCF Based) vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Maternus-Kliniken AG's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Maternus-Kliniken AG's Margin of Safety % (DCF FCF Based) falls into.


STU:MAK
38GF Score
Maternus-Kliniken AG STU:MAK
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Maternus-Kliniken AG (STU:MAK) Overvalued in 2026?

Based on GuruFocus' analysis, Maternus-Kliniken AG stock appears to be undervalued. The current stock price of €0.95 is trading 46.6% below its estimated GF Value™ of €1.77. GuruFocus considers Maternus-Kliniken AG to be Possible Value Trap.

Key valuation signals for STU:MAK:

  • Margin of Safety % (DCF FCF Based): N/A
  • GF Value™: €1.77 vs. price of €0.95 (46.6% below fair value)
  • GF Score™: 38/100 with 4 warning signs

No single metric tells the full story. See the STU:MAK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Maternus-Kliniken AG Business Description

Other Exchanges 0N2K:UK
Address Strasse 53 - 55, Berlin, DEU, 10117
Maternus-Kliniken AG operates as a German healthcare company focused on senior housing, care facilities, and rehabilitation clinics.
38GF Score

Get the complete analysis for STU:MAK

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.95
Price
€1.77
GF Value